Get the Government Out of the GLP-1 Market

Dr. Gilberto de Lima Lopes Jr. is right that the market for medications is imperfect, but it is often government that is the culprit (“The Free Market Alone Won’t Cut GLP-1 Prices,” Letters, Nov. 21).

- Dana P. GOLDMAN

Oncology, his speciality, is the canonical example of government distortion. In Medicare, cancer medications are often reimbursed through the Part B program. Providers get a percentage of the sales price for administering each drug, so it’s hardly